Laura-mae Britton

Director, Scientific Communications And Publications - Medical Affairs at Servier Pharmaceuticals in New York, New York, United States

Verified profile l***@servier.com
Job Title
Director, Scientific Communications And Publications - Medical Affairs
Company
Servier Pharmaceuticals
Location
New York, New York, United States
Seniority
Director
Industry
Pharmaceuticals
Company Size
920 employees
Work Email
l***@servier.com
Laura-mae's full work email still locked
Reveal Laura-mae's verified work email - free

Free account. Verified against live company records.

You'll unlock:
  • Laura-mae's full verified work email
  • LinkedIn and full company profile

Laura-mae Britton is the Director, Scientific Communications And Publications - Medical Affairs at Servier Pharmaceuticals based in New York, New York, United States.

Colleagues at Servier Pharmaceuticals

Other verified contacts at Servier Pharmaceuticals.

Other people named Laura-mae Britton

Different professionals who share this name.

Frequently asked

What is Laura-mae Britton's email address?

Laura-mae Britton's work email follows the pattern l***@servier.com. Reveal it free.

What does Laura-mae Britton do?

Laura-mae Britton is the Director, Scientific Communications And Publications - Medical Affairs at Servier Pharmaceuticals.

Where is Laura-mae Britton based?

New York, New York, United States.

Who is the Director, Scientific Communications And Publications - Medical Affairs at Servier Pharmaceuticals?

Laura-mae Britton.

Get Laura-mae Britton's verified contact details

Reveal the full work email and more. Free to start.

Try ScraperCity Free →
Run an agency? If you look up leads like this to sell your services, I coach agency owners on getting clients. You get 4 coaching calls a week, my courses and a private community. Cancel anytime. It is $597 a month if you join by Dec 31; new members pay $797 from Jan 1. - Alex Berman See Galadon Gold

Not ready yet? Leave your email and we'll send you the details, plus one reminder before the price changes on January 1.